Neutralizing response elicited by homologous and heterologous prime booster vaccination against ancestral SARS-CoV-2 B.1, P.1, C.37 and B.1.617.2 variants
Heterologous Covid-19 vaccination strategies arose due to interruption of vaccination programs plus delay and shortage of vaccine supplies. We analysed neutralizing response against ancestral SARS-CoV-2 B.1 and P.1, C.37 and B.1.67.2 variants elicited by 16 homologous and heterologous protocols comb...
Guardado en:
Autores principales: | , , , , , , , , |
---|---|
Formato: | Artículo |
Lenguaje: | Español |
Publicado: |
Elsevier Ltd
2022
|
Materias: | |
Acceso en línea: | http://pa.bibdigital.ucc.edu.ar/3507/1/A_Blanco_Spinsanti_Aguilar.pdf |
Aporte de: |
id |
I38-R144-3507 |
---|---|
record_format |
dspace |
institution |
Universidad Católica de Córdoba |
institution_str |
I-38 |
repository_str |
R-144 |
collection |
Producción Académica Universidad Católica de Córdoba (UCCor) |
language |
Español |
orig_language_str_mv |
spa |
topic |
R Medicina (General) RB Patología |
spellingShingle |
R Medicina (General) RB Patología Blanco, Sebastián Spinsanti, Lorena Aguilar, Juan Javier Diaz, Adrián Beranek, Mauricio Fernández, Elmer Andrés Mangeaud, Arnaldo Pedro Konigheim, Brenda Salomé Gallego, Sandra Verónica Neutralizing response elicited by homologous and heterologous prime booster vaccination against ancestral SARS-CoV-2 B.1, P.1, C.37 and B.1.617.2 variants |
topic_facet |
R Medicina (General) RB Patología |
description |
Heterologous Covid-19 vaccination strategies arose due to interruption of vaccination programs plus delay and shortage of vaccine supplies. We analysed neutralizing response against ancestral SARS-CoV-2 B.1 and P.1, C.37 and B.1.67.2 variants elicited by 16 homologous and heterologous protocols combining Gam-COVID-Vac, ChAdOx1-S, Ad5-nCorV, BBIBP-CorV and mRNA-1273 vaccines. Homologous mRNA-1273 and heterologous schemes of a non-replicative viral vector/inactivated virus-based vaccine combined with mRNA-1273 induced significantly broader and greater neutralizing antibody-response. Moreover, serum from participants vaccinated with combinations of ChAdOx1-S/Ad5-nCorV and BBIBP-CorV/non-replicative viral vector-based vaccines showed higher or equivalent neutralizing response compared to homologous protocols, pointing them as good alternative platforms. BBIBP-CorV used as second dose exhibited significantly lower neutralizing response compared to other protocols, demonstrating that it should not be recommended as second dose. The information provided herein is valuable to redesign vaccination strategies, especially for low-income countries that still struggle with low percentages of immunized populations and vaccine supply shortage. |
format |
Artículo Artículo |
author |
Blanco, Sebastián Spinsanti, Lorena Aguilar, Juan Javier Diaz, Adrián Beranek, Mauricio Fernández, Elmer Andrés Mangeaud, Arnaldo Pedro Konigheim, Brenda Salomé Gallego, Sandra Verónica |
author_facet |
Blanco, Sebastián Spinsanti, Lorena Aguilar, Juan Javier Diaz, Adrián Beranek, Mauricio Fernández, Elmer Andrés Mangeaud, Arnaldo Pedro Konigheim, Brenda Salomé Gallego, Sandra Verónica |
author_sort |
Blanco, Sebastián |
title |
Neutralizing response elicited by homologous and heterologous prime booster vaccination against ancestral SARS-CoV-2 B.1, P.1, C.37 and B.1.617.2 variants |
title_short |
Neutralizing response elicited by homologous and heterologous prime booster vaccination against ancestral SARS-CoV-2 B.1, P.1, C.37 and B.1.617.2 variants |
title_full |
Neutralizing response elicited by homologous and heterologous prime booster vaccination against ancestral SARS-CoV-2 B.1, P.1, C.37 and B.1.617.2 variants |
title_fullStr |
Neutralizing response elicited by homologous and heterologous prime booster vaccination against ancestral SARS-CoV-2 B.1, P.1, C.37 and B.1.617.2 variants |
title_full_unstemmed |
Neutralizing response elicited by homologous and heterologous prime booster vaccination against ancestral SARS-CoV-2 B.1, P.1, C.37 and B.1.617.2 variants |
title_sort |
neutralizing response elicited by homologous and heterologous prime booster vaccination against ancestral sars-cov-2 b.1, p.1, c.37 and b.1.617.2 variants |
publisher |
Elsevier Ltd |
publishDate |
2022 |
url |
http://pa.bibdigital.ucc.edu.ar/3507/1/A_Blanco_Spinsanti_Aguilar.pdf |
work_keys_str_mv |
AT blancosebastian neutralizingresponseelicitedbyhomologousandheterologousprimeboostervaccinationagainstancestralsarscov2b1p1c37andb16172variants AT spinsantilorena neutralizingresponseelicitedbyhomologousandheterologousprimeboostervaccinationagainstancestralsarscov2b1p1c37andb16172variants AT aguilarjuanjavier neutralizingresponseelicitedbyhomologousandheterologousprimeboostervaccinationagainstancestralsarscov2b1p1c37andb16172variants AT diazadrian neutralizingresponseelicitedbyhomologousandheterologousprimeboostervaccinationagainstancestralsarscov2b1p1c37andb16172variants AT beranekmauricio neutralizingresponseelicitedbyhomologousandheterologousprimeboostervaccinationagainstancestralsarscov2b1p1c37andb16172variants AT fernandezelmerandres neutralizingresponseelicitedbyhomologousandheterologousprimeboostervaccinationagainstancestralsarscov2b1p1c37andb16172variants AT mangeaudarnaldopedro neutralizingresponseelicitedbyhomologousandheterologousprimeboostervaccinationagainstancestralsarscov2b1p1c37andb16172variants AT konigheimbrendasalome neutralizingresponseelicitedbyhomologousandheterologousprimeboostervaccinationagainstancestralsarscov2b1p1c37andb16172variants AT gallegosandraveronica neutralizingresponseelicitedbyhomologousandheterologousprimeboostervaccinationagainstancestralsarscov2b1p1c37andb16172variants |
bdutipo_str |
Repositorios |
_version_ |
1764820536035115011 |